RecruitingNCT03408353

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort


Sponsor

M.D. Anderson Cancer Center

Enrollment

10,000 participants

Start Date

Sep 15, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.


Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 80 Years

Inclusion Criteria3

  • Willingness to participate in the study and ability to provide informed consent
  • Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits
  • Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.

Exclusion Criteria3

  • Current or recent (within the prior 6 months) history of breast feeding
  • Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer)
  • Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.

Interventions

PROCEDUREBiospecimen Collection

Undergo collection of blood samples

PROCEDUREMammography

Undergo standard of care mammography

OTHERQuestionnaire Administration

Complete questionnaires


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03408353


Related Trials